fda glp-1 safety warning september 2025 How safe are GLP-1s? September 8, 2025: FDA launches
Description
Are they right for me
Gain insights for a healthier you.
Discover the differences between Ozempic and Mounjaro for safe weight loss
Eight studies comprised of 715 children and adolescents were included
Recent research has found that the use of GLP-1 receptor agonists such as Ozempic during pregnancy is no more likely to lead to congenital malformations in infants than insulin use.
Ozempic (semaglutide) is an FDA-approved glucagon-like peptide-1 receptor agonist (GLP-1) receptor agonist made by Novo Nordisk
